ED Legal Letter articles from May 2008

ED Legal Letter archives from May 2008

Off-Label Prescribing: What Are the Medical-Legal Risks?
May 1, 2008... Off-Label Prescribing: What Are the Medical-Legal Risks? By James E. Szalados, MD, MBA, Esq., Critical Care Medicine, Unity and Via Health Systems, Westside Anesthesiology Associates of Rochester, LLP, Vice President for Medical Affairs...

ED physicians more often sued for not giving tPA for stroke.
May 1, 2008... ED physicians more often sued for not giving tPA for stroke Controversy engenders "incredible amount of liability" Emergency physicians are much more likely to be sued for not administering tissue plasminogen activator (tPA) to stroke...

What if it's not safe to give tPA in your hospital?
May 1, 2008... What if it's not safe to give tPA in your hospital? Poor monitoring, transfer delays can result in lawsuits Before giving a stroke patient tissue plasminogen activator (tPA), you must consider not only whether the patent is a candidate,...

E-mail leaves "paper trail" lawyers may utiliz.
May 1, 2008... E-mail leaves "paper trail" lawyers may utilize "Controversial" messages can be devastating evidence Imagine this e-mail from one of your colleagues being Exhibit A at your malpractice trial: "You misdiagnosed Jane Doe with indigestion...

CNE/CME Questions.
May 1, 2008... CNE/CME Questions 19. The labeling submitted by a drug manufacturer with the new drug application (NDA) must reflect which of the following? A. The intended use or uses of the drug based on the studies conducted and the scientific data...